Akèy › Alèji
Etid klinik pou Alèji ap rekrite nan Etazini
24 etid pou Alèji ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA6 etid
- New York City, NY6 etid
- Nashville, TN5 etid
- Mountain View, CA4 etid
- Ann Arbor, MI4 etid
- Washington, DC4 etid
- Durham, NC3 etid
- Baltimore, MD3 etid
- Chicago, IL3 etid
- Cincinnati, OH3 etid
Pa eta
- Arizona4 etid
- Illinois4 etid
- Kalifòni7 etid
- Maryland5 etid
- Massachusetts6 etid
- Michigan4 etid
- New York9 etid
- North Carolina3 etid
- Ohio3 etid
- Tennessee5 etid
- Texas5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Ap rekriteEtid obsèvasyon
Laj 1 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001406(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG
Ap rekriteFaz 2
Laj 12 a 50 · Tout sèks · Mizajou Sep 9, 2026 · NCT07611435Study of Oral Food Challenge Biomarkers (SAFER)
Ap rekriteEtid obsèvasyon
12 Months – 17 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT07279467Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 4, 2026 · NCT06406114Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091Registry of Asthma Characterization and Recruitment 3 (RACR3)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT05272241Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07605806Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
Ap rekriteVolontè an sante akeyi
1 Day · Fanm · Mizajou Jul 20, 2026 · NCT06260956A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Ap rekriteEtid obsèvasyon
Laj 3 a 100 · Tout sèks · Mizajou Jul 17, 2026 · NCT06732414Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome
Ap rekrite
Laj 1 a 60 · Tout sèks · Mizajou Jun 1, 2026 · NCT06683521LYmph Node eXamination in Cat Allergen Immunotherapy
Ap rekriteFaz 1 bonè
Laj 18 a 45 · Tout sèks · Mizajou May 1, 2026 · NCT07447869Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Ap rekriteFaz 4
Laj 4 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT06834165Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Week – 90 Years · Tout sèks · Mizajou Mar 17, 2026 · NCT04828603Sensory Symptoms in Tourette Syndrome
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT03851484A Clinical Trial of Soluble Fiber for Asthma
Ap rekriteFaz 2Mande peman pou patisipan yo
Laj 6 a 17 · Tout sèks · Mizajou Mar 4, 2026 · NCT06372249Omalizumab Weight-Based Dosing Efficacy Trial
Ap rekriteFaz 2
Laj 1 a 55 · Tout sèks · Mizajou Feb 5, 2026 · NCT06943534Allergy and Immunology Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 99 · Tout sèks · Mizajou Feb 4, 2026 · NCT05584488BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT05341726Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
Ap rekriteVolontè an sante akeyi
Laj 10 a 55 · Tout sèks · Mizajou Nov 25, 2025 · NCT06300697Food Allergy Registry at a Single Site
Ap rekriteEtid obsèvasyon
Laj 0 a 100 · Tout sèks · Mizajou Nov 14, 2025 · NCT03539705Group CBT in Parents of Children With Food Allergy
Ap rekrite
18 Months – 17 Years · Tout sèks · Mizajou Apr 16, 2025 · NCT06138431Viral Mucosal Reprogramming
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Jan 28, 2025 · NCT05331170Innate Immunity in Allergic Asthma
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Dec 6, 2024 · NCT06068335Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.